Gts Securities »

Sab Biotherapeutics shares owned by Gts Securities

Quarter-by-quarter ownership of Sab Biotherapeutics (SABSW) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Gts Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.0k 41k 0.03

More positions owned by Gts Securities

Entrepreneurshares Series Tr Ershares Private (XOVR)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Apple (AAPL)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 2000 Etf (IWM)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Msci India Etf (INDA)
Netflix (NFLX)
Select Sector Spdr Tr State Street Tec (XLK)
Ishares Tr China Lg-cap Etf (FXI)

View all positions for Gts Securities

Top funds holding Sab Biotherapeutics

Millennium Management
Gts Securities
UBS Group
Wolverine Asset Management
Goss Wealth Management
Toronto-Dominion Bank

View all funds holding Sab Biotherapeutics